Antenatal lamivudine to reduce perinatal hepatitis B transmission: a cost-effectiveness analysis
Nayeri UA, Werner EF, Han CS, Pettker CM, Funai EF, Thung SF. Antenatal lamivudine to reduce perinatal hepatitis B transmission: a cost-effectiveness analysis. American Journal Of Obstetrics And Gynecology 2012, 207: 231.e1-231.e7. PMID: 22939730, DOI: 10.1016/j.ajog.2012.06.001.Peer-Reviewed Original ResearchConceptsChronic hepatitis BHepatitis BLamivudine administrationPerinatal transmissionThird trimesterPregnant womenPerinatal hepatitis B transmissionAdministration of lamivudineMaternal hepatitis BHepatitis B transmissionCost-effectiveness analysisDecision analysis modelExpectant managementLiver transplantPregnant patientsHepatocellular carcinomaB transmissionLamivudineCost-effective strategyAdministrationTrimesterPregnancyWomenPatientsCarcinoma
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply